Company Filing History:
1 out of 1,743 
1 out of 141 
Years Active: 2009
Title: Agnès Aubry: Innovator in Antitumoral Immunotherapy
Introduction
Agnès Aubry is a notable inventor based in Nantes, France. He has made significant contributions to the field of immunotherapy, particularly in the development of peptides derived from the protein MMP-2. His work focuses on utilizing these peptides for antitumoral applications, showcasing his commitment to advancing cancer treatment.
Latest Patents
Agnès Aubry holds a patent titled "Peptides derived from the protein MMP-2, and the use thereof in antitumoral immunotherapy." This patent involves peptides derived from MMP-2 metalloproteinase that form T cell epitopes when presented by MHC Class I molecules. The innovative anti-tumor therapy using these peptides represents a promising advancement in cancer treatment.
Career Highlights
Throughout his career, Agnès Aubry has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université de Nantes. His experience in these organizations has allowed him to contribute significantly to research and development in the medical field.
Collaborations
Agnès Aubry has collaborated with notable colleagues, including Yannick Guilloux and Francine Jotereau. These partnerships have further enriched his research and innovation efforts.
Conclusion
Agnès Aubry's work in antitumoral immunotherapy exemplifies the impact of innovative research in the fight against cancer. His contributions through patents and collaborations highlight the importance of continued advancements in medical science.